3 Nov 2017 (Friday)
Venue : Auditorium, Hong Kong Adventist Hospital – Tsuen Wan

8:40 - 8:50am Welcome and introduction Joseph Siu-Kie Au, Chairman of organizing committee, HKIOS
8:50- 9:00am Opening Mr. Alex Lan, CEO, Hong Kong Adventist Hospital

Big Data Analysis
Chairpersons : William Cho (QEH), Ronnie Poon (HKIOC)

9:00 - 9:30am Pathogenesis and biomarkers for Hepatocellular carcinoma Raymond Yeung, University of Washington, Seattle, USA
9:30- 10:00am Cellular heterogeneity of cancers and resolutions of our technologies Yu Jun, Beijing Institute of Genomics, Chinese Academy of Medicine
10:00 - 10:30am Big data analysis: reading the book of life Qiangfeng Cliff Zhang, Tsinghua University, China
10:30 - 10:40am Panel discussion and Q&A
10:30- 11:00am Break

Chairpersons : Rebecca Chin(City U), Stanley Leung(HKAH)

11:00 - 11:30am CD19 CAR-T cell therapy for B cell malignancies Cameron J.Turtle,University of Washington, Seattle, USA
11:30- 12:00nn The quest for check point inhibitors biomarkers Shu Jen Chen, Taiwan Precision Medicine Society
12:00nn - 12:30pm Overview of immune checkpoint inhibitors for solid tumours Joseph Siu Kie Au, Hong Kong Adventist Hospital
12:30 - 1:00pm Heralding a New Era of Cancer Vaccines Lei Zheng, Johns Hopkins University School of Medicine
1:00- 1:10pm Panel discussion Q&A

Advances in Urogenital Cancers
Chairpersons : Lung Wai Chan(HKAH), Andrew Wai Chun Yip(Specialist in Urology)

2:00 - 2:45pm Surgical management of prostate and urothelial cancer Edmond Wong, Hong Kong Adventist Hospital
2:45 - 3:15pm Radiotherapy of localized prostate cancer Ronald Chen, Department of Radiation Oncology,UNC-Chapel Hill,USA
3:15- 4:00pm Systemic treatment for advanced prostate cancer F Y Cheung, Hong Kong Integrated Oncology Centre
4:00 - 4:45pm Systemic treatment for advanced or disseminated urothelial cancer Philip Kwong, Queen Mary Hospital
4:45 - 4:55pm Panel discussion Q&A

4 Nov 2017 (Saturday)
Venue : 19/F,AC3 Building, City University of Hong Kong

8:20 - 8:30am Day 2 : Opening speech Dr.Stephen C K Law, Hong College of Radiologists

Chairpersons : William Foo(HKBH), Michael Yang(City U)

8:30 - 9:00am Management of metastatic estrogen receptor-positive breast cancers Roger Ngan, Queen Elizabeth Hospital
9:00 - 9:30am Leverage high throughput data for pharmacogenomic discovery and drug repurposing Stephanie Huang , University of Minnesota
9:30 -10:00am Functional genomic approaches in precision oncology: a case study in identifying new therapeutic targets for glioblastoma Patrick Paddison, Fred Hutchinson Cancer Research Center, USA
10:00 - 10:30am In vitro cancer tissue models Josephine Wong, University College London
10:30 - 10:45am Panel discussion Q&A

Advances in Lung Cancer
Chairpersons : Carol Kwok(PMH), Dora Kwong(HKU)

10:45 - 11:15am Challenges in the surgical management of lung cancer Ju-wei Mu, Shen Zhen Center, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
11:15 - 11:45am The use of radiation to generate an anti-tumor immune response in non-small cell lung cancer Ramesh Rengan, University of Washington, USA
11:45 - 12:05pm Anti-angiogenesis in lung cancer Oscar Chan, Pamela Youde Nethersole Eastern Hospital
12:05 - 12:20pm Diagnosis and treatment of ALK positive non-small cell lung cancer in Cancer Hospital Chinese Academy of Medical Sciences Jun-Ling Li, Cancer Hospital Chinese Academy of Medical Sciences
12:20- 12:35pm Overcoming EGFR TKI resistance Jacky Li, Queen Elizabeth Hospital
12:35 - 12:45pm Experience of SABR in NSCLC Jeannie Chik, Queen Elizabeth Hospital
12:45 - 1:00pm Panel discussion Q&A
12:45 - 1:45pm Lunch

Precision Radiotherapy
Chairpersons : lnda Soong(PYNEH), Frank Wong(TMH)

1:45 - 2:10pm Fractionated Stereotactic Radiotherapy for Optic Nerve Sheath Meningioma at the BCCA Roy MA, BC Cancer Agency, Canada
2:10 - 2:35pm Skin and urothelial cancer Patricia Tai, Allan Blair Cancer Center, Regina,SK, Canada
2:35 - 3:00pm Lung and oligo-metastases, SBRT spine Mitchell Liu, BC Cancer Agency, Canada
3:00 - 3:25pm Head and Neck Cancers John Wu, BC Cancer Agency, Canada
3:25 - 3:50pm Proton Therapy Tony Wong, Seattle Cancer Care Alliance, USA
3:50 - 4:00pm Panel discussion Q&A  

Precision Oncology
Chairpersons : Stephen Yau(HKNOS), Timothy Yip(ACT genomics)

4:00 - 4:30pm Clinical application of NGS Shu Jen Chen, Taiwan Precision Medicine Society
4:30 - 5:00pm Precision Cancer Imaging Michael Yang, Hong Kong Integrated Oncology Centre
5:00 - 5:30pm Potential clinical application of multiple target receptor tyrosine kinase inhibitors(RTKI) Yasuhiro Funahashi, phD EWAY Laboratory, Translational Science Dpt, OBG, Eisai Co, Ltd.
5:30 - 5:40pm Panel discussion and Q&A  

Tour of City University and Gala dinner at Staff Restaurant (6:00pm - 10:00pm)

Copyright © http://www.iso.org.hk All Right Reserved